Stefano Casola

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Science advances

Cancer research

Immunological reviews

Communications biology

IFOM, the FIRC Institute of Molecular Oncology

Universita degli Studi di Napoli Federico II (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IFOM, the FIRC Institute of Molecular Oncology

Italy

Senior group Leader

IFOM, The FIRC Institute of Molecular Oncology

Italy

Junior Group Leader

Harvard Medical School

United States

Instructor :: Pathology

The CBR institute of Biomedical Research

United States

Junior Investigator

Institute of Genetics, University of Cologne

Germany

Post-doctoral fellow

Education History

Universita degli Studi di Napoli Federico II

Italy

PHD

Publications

Franca Raucci, Claudio Vernieri, Maira Di Tano, Francesca Ligorio, Olga Blaževitš, Samuel Lazzeri, Anastasiya Shmahala, Giuseppe Fragale, Giulia Salvadori, Gabriele Varano, Stefano Casola, Roberta Buono, Euplio Visco, Filippo G De Braud, Valter Daniel Longo
Cyclic fasting-mimicking diet plus bortezomib and rituximab is an effective treatment for chronic lymphocytic leukemia. Cancer research (2024)
Franca Raucci, Claudio Vernieri, Maira Di Tano, Francesca Ligorio, Olga Blaževitš, Samuel Lazzeri, Anastasiya Shmahala, Giuseppe Fragale, Giulia Salvadori, Gabriele Varano, Stefano Casola, Roberta Buono, Euplio Visco, Filippo G De Braud, Valter Daniel Longo
Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia. Cancer research 84 (7) (2024)
Judith Mary Hariprakash, Elisa Salviato, Federica La Mastra, Endre Sebestyén, Ilario Tagliaferri, Raquel Sofia Silva, Federica Lucini, Lorenzo Farina, Mario Cinquanta, Ilaria Rancati, Mirko Riboni, Simone Paolo Minardi, Luca Roz, Francesca Gorini, Chiara Lanzuolo, Stefano Casola, Francesco Ferrari
Leveraging tissue-specific enhancer-target gene regulatory networks identifies enhancer somatic mutations that functionally impact lung cancer. Cancer research (2023)
Armela Huda, Hiroshi Arakawa, Giulia Mazzucco, Martina Galli, Valentina Petrocelli, Stefano Casola, Lu Chen, Ylli Doksani
The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats. Science advances 9 (12) (2023)
Armela Huda, Hiroshi Arakawa, Giulia Mazzucco, Martina Galli, Valentina Petrocelli, Stefano Casola, Lu Chen, Ylli Doksani
The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats. Science advances 9 (12) (2023)
Armela Huda, Hiroshi Arakawa, Giulia Mazzucco, Martina Galli, Valentina Petrocelli, Stefano Casola, Lu Chen, Ylli Doksani
The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats. Science advances 9 (12) (2023)
Francesca Copperi, Inna Schleis, Martin Roumain, Giulio G Muccioli, Stefano Casola, Martin Klingenspor, Alexander Pfeifer, Thorsten Gnad
EBI2 is a negative modulator of brown adipose tissue energy expenditure in mice and human brown adipocytes. Communications biology 5 (1) (2022)
Stefano Casola, Laura Perucho, Claudio Tripodo, Paola Sindaco, Maurilio Ponzoni, Fabio Facchetti
The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance. Immunological reviews 288 (1) (2019)

Stefano Casola.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stefano Casola